Loading...
Oscar Health, Inc.
OSCR•NYSE
HealthcareMedical - Healthcare Plans
$15.43
$-0.23(-1.44%)
Oscar Health, Inc. (OSCR) Financial Performance & Statements
Review Oscar Health, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
56.54%
↑ 56.54%
Operating Income Growth
124.30%
↑ 124.30%
Net Income Growth
109.39%
↑ 109.39%
Operating Cash Flow Growth
459.42%
↑ 459.42%
Operating Margin
1.59%
↑ 1.59%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
1.22%
↑ 1.22%
ROE
10.61%
↑ 10.61%
ROIC
9.43%
↑ 9.43%
Oscar Health, Inc. (OSCR) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Oscar Health, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.39B | $2.42B | $2.22B | $2.14B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | -$1.00 |
| Gross Profit | $2.39B | $2.42B | $2.22B | $2.14B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.000 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $466.58M | $459.52M | $435.14M | $394.70M |
| Operating Expenses | $2.54B | $2.47B | $442.81M | $401.97M |
| Total Costs & Expenses | $2.54B | $2.47B | -$2.15B | -$1.96B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $6.03M | $5.82M | $5.99M | $5.90M |
| Depreciation & Amortization | $9.23M | $7.50M | $7.60M | $7.81M |
| EBITDA | -$138.69M | -$39.20M | $74.54M | $192.19M |
| EBITDA Ratio | -$0.06 | -$0.02 | $0.03 | $0.09 |
| Operating Income | -$147.73M | -$48.37M | $67.81M | $185.56M |
| Operating Income Ratio | -$0.06 | -$0.02 | $0.03 | $0.09 |
| Other Income/Expenses (Net) | -$5.96M | -$3.94M | -$6.86M | -$7.08M |
| Income Before Tax | -$153.69M | -$52.31M | $60.95M | $178.48M |
| Income Before Tax Ratio | -$0.06 | -$0.02 | $0.03 | $0.08 |
| Income Tax Expense | -$404000.00 | $2.08M | $4.64M | $996000.00 |
| Net Income | -$153.55M | -$54.60M | $56.21M | $177.37M |
| Net Income Ratio | -$0.06 | -$0.02 | $0.03 | $0.08 |
| EPS | -$0.62 | -$0.22 | $0.24 | $0.77 |
| Diluted EPS | -$0.62 | -$0.22 | $0.18 | $0.60 |
| Weighted Avg Shares Outstanding | $248.21M | $243.11M | $238.67M | $231.44M |
| Weighted Avg Shares Outstanding (Diluted) | $248.21M | $243.11M | $303.96M | $293.80M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan